The Guardian · uk

‘Bespoke’ mRNA vaccine significantly reduces risk of melanoma recurrence or death, clinical trial shows

Trial results represent ‘foundational shift’ in approach to cancer, allowing scientists to harness immune system in more personalised way Get our new political email, free app or daily news podcast A personalised mRNA-b…

Den ganzen Text gibt es bei der Zeitung. Wir behalten nur den Vorspann.